102 related articles for article (PubMed ID: 16215894)
21. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin.
Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC
Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of antibiotics in critically ill patients.
van Dalen R; Vree TB
Intensive Care Med; 1990; 16 Suppl 3():S235-8. PubMed ID: 2289997
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
[TBL] [Abstract][Full Text] [Related]
24. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
Pea F; Brollo L; Viale P; Pavan F; Furlanut M
J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
[TBL] [Abstract][Full Text] [Related]
25. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
26. Albumin regeneration in liver support-comparison of different methods.
Mitzner S; Klammt S; Stange J; Schmidt R
Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery.
Shinagawa N
J Chemother; 1989 Jul; 1(4 Suppl):524-5. PubMed ID: 16312514
[No Abstract] [Full Text] [Related]
28. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
[No Abstract] [Full Text] [Related]
29. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
30. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.
Yano R; Nakamura T; Tsukamoto H; Igarashi T; Goto N; Wakiya Y; Masada M
Ther Drug Monit; 2007 Aug; 29(4):399-403. PubMed ID: 17667792
[TBL] [Abstract][Full Text] [Related]
31. Treatment of acute hepatic encephalopathy.
Chamuleau RA
Neth J Med; 1979; 22(6):203-9. PubMed ID: 118390
[No Abstract] [Full Text] [Related]
32. Methods of extracorporeal liver support for treatment of liver cell failure.
Adham M
Z Gastroenterol; 2001 Jun; 39 Suppl 2():1-5. PubMed ID: 16215880
[No Abstract] [Full Text] [Related]
33. [Hepatic coma, caused by viral hepatitis, successful treatment by hyperbaric oxygen].
Dordain M; Humbert G; Robert M; Leroy J; Delaunay P
Sem Hop; 1968 Oct; 44(43):2617-22. PubMed ID: 4310575
[No Abstract] [Full Text] [Related]
34. Outbreak of neonatal Klebsiella septicaemia: a review of antimicrobial sensitivities.
Akindele JA; Rotilu IO
Afr J Med Med Sci; 1997; 26(1-2):51-3. PubMed ID: 10895230
[TBL] [Abstract][Full Text] [Related]
35. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
[TBL] [Abstract][Full Text] [Related]
36. [An emerging concept: pharmacokinetic changes in antibiotics eliminated by the kidney in liver diseases. Mechanisms].
Palatini P
G Ital Chemioter; 1991; 38(1-3):19-21. PubMed ID: 1365588
[No Abstract] [Full Text] [Related]
37. [Current possibilities and perspectives of the combined treatment of patients with severe bronchopulmonary diseases].
Sokolova VI; Shenderovich VA; Orlov VA; Elagina LV
Antibiot Khimioter; 2002; 47(8):16-9. PubMed ID: 12515092
[TBL] [Abstract][Full Text] [Related]
38. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).
Sauer IM; Goetz M; Steffen I; Walter G; Kehr DC; Schwartlander R; Hwang YJ; Pascher A; Gerlach JC; Neuhaus P
Hepatology; 2004 May; 39(5):1408-14. PubMed ID: 15122770
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal albumin dialysis.
Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
[TBL] [Abstract][Full Text] [Related]
40. Developing an assay for ceftazidime: is it worth the effort?
van den Anker J
Ther Drug Monit; 2011 Feb; 33(1):132. PubMed ID: 21233691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
